Atherosclerosis 1997: Vol 135 Index

5 Pages·1997·1.6 MB·English

atherosclerosis
SEVIER Atherosclerosis 135 (1997) 273-275
Author index
Volume 135 (1997)
Abbey, M., see Kerry, N.L. 135, 93 Faggiotto, A., see Bischoff, H. 135, 119
Abdel-Wareth, L.O., S.N. Pimstone, J.-P. Lagarde, A. Raisonnier, P. Figueroa, J.E., see Tao, Z. 135, 171
Benlian, H. Pritchard, M.R. Hayden, J.J. Frohlich, Familial defec- Finking, G., H. Hanke, Nikolaj Nikolajewitsch Anitschkow (1885-—
tive apolipoprotein B-100 in hypercholesterolemic Chinese Canadi- 1964) established the cholesterol-fed rabbit as a model for
ans: identification of a unique haplotype of the apolipoprotein atherosclerosis research 135, 1
B-100 allele 135, 181 Fisher, R.M., S.E. Humphries, P.J. Talmud, Common variation in
Akira Takei, see Lopes-Virella, M.F. 135, 161 the lipoprotein lipase gene: effects on plasma lipids and risk of
Anami, Y., see Yano, T. 135, 57 atherosclerosis 135, 145
Anami, Y., S. Kobori, M. Sakai, M. Kasho, T. Nishikawa, T. Yano, Forslund, L., see Held, C. 135, 109
H. Matsuda, T. Matsumura, T. Takemura, M. Shichiri, Human Frohlich, J.J., see Abdel-Wareth, L.O. 135, 181
f-migrating very low density lipoprotein induces foam cell forma- Fusano, T., see Takeshita, S. 135, 187
tion in human mesangial cells 135, 225
Andreeva, E.R., I.M. Pugach, A.N. Orekhov, Subendothelial smooth Glancy, D.L., see Tao, Z. 135, 171
muscle Cells of human aorta express macrophage antigen in situ Gosling, R.G., see Lehmann, E.D. 135, 263
and in vitro 135, 19 Gouda, N., see Irokawa, M. 135, 9
Angelin, B., see Held, C. 135, 109 Graham, A., D.G. Hassall, S. Rafique, J.S. Owen, Evidence for a
Angerbauer, R., see Bischoff, H. 135, 119 paraoxonase-independent inhibition of low-density lipoprotein oxi-
dation by high-density lipoprotein 135, 193
Badimon, L., see Martinez-Gonzalez, J. 135, 213
Behra, A., see Brandes, R.P. 135, 49 Hanke, H., see Finking, G. 135, 1
Bender, J., see Bischoff, H. 135, 119 Harada, K., Z. Chen, S. Ishibashi, J.-i. Osuga, H. Yagyu, K. Ohashi,
Benlian, P., see Abdel-Wareth, L.O. 135, 181 N. Yahagi, F. Shionoiri, L. Sun, Y. Yazaki, N. Yamada, Apop-
Berglund, L., see Held, C. 135, 109 totic cell death in atherosclerotic plaques of hyperlipidemic knock-
Binzafar, N., see Lopes-Virella, M.F. 135, 161 out mice 135, 235
Bischoff, E., see Bischoff, H. 135, 119 Hassall, D.G., see Graham, A. 135, 193
Bischoff, H., R. Angerbauer, J. Bender, E. Bischoff, A. Faggiotto, D. Hayden, M.R., see Abdel-Wareth, L.O. 135, 181
Petzinna, J. Pfitzner, M.C. Porter, D. Schmidt, G. Thomas, Held, C., P. Hjemdahl, N. Rehngqvist, I. BjOrkander, L. Forslund, U.
Cerivastatin: pharmacology of a novel synthetic and highly active Brodin, L. Berglund, B. Angelin, Cardiovascular prognosis in
HMG-COA reductase inhibitor 135, 119 relation to apolipoproteins and other lipid parameters in patients
BjOrkander, I., see Held, C. 135, 109 with stable angina pectoris treated with verapamil or metoprolol:
Bode-Béger, $.M., see Brandes, R.P. 135, 49 Results from the Angina Prognosis Study in Stockholm (AP-
BOger, R.H., see Brandes, R.P. 135, 49 SIS) 135, 109
Brandes, R.P., A. Behra, C. Lebherz, R.H. Boger, S.M. Bode-Boger, Hjemdahl, P., see Held, C. 135, 109
L. Phivthong-Ngam, A. Miigge, N®©-nitro-L-arginine- and in- Humphries, S.E., see Fisher, R.M. 135, 145
domethacin-resistant endothelium-dependent relaxation in the rab-
bit renal artery: effect of hypercholesterolemia 135, 49 Iguchi, A., see Naito, M. 135, 241
Brodin, U., see Held, C. 135, 109 Ikeda, U., see Irokawa, M. 135, 9
Bruneval, P., see Péterszegi, G. 135, 103 Illingworth, D.R., see Raal, F.J. 135, 249
Irokawa, M., M. Nishinaga, U. Ikeda, Y. Shinoda, M. Suematsu, N.
Cameron, J.D., see Dart, A.M. 135, 269 Gouda, Y. Ishimura, K. Shimada, Endothelial-derived nitric oxide
Chau, L.-Y., see Yen, H.-C. 135, 29 preserves anticoagulant heparan sulfate expression in cultured
Chen, Z., see Harada, K. 135, 235 porcine aortic endothelial cells 135, 9
Croft, K.D., see Riches, F.M. 135, 83 Ishibashi, S., see Harada, K. 135, 235
Ishikawa, T., see Takeshita, S. 135, 187
Dart, A.M., X.L. Qi, J.D. Cameron, In vivo determinants of arterial Ishimura, Y., see Irokawa, M. 135, 9
biophysical properties: methodological considerations: (Reply to Isshiki, T., see Takeshita, S. 135, 187
Lehmann and Gosling) 135, 269
Kasho, M., see Anami, Y. 135, 225
Esaki, T., see Naito, M. 135, 241 Kasho, M., see Yano, T. 135, 57
PIT §0021-9150(97)00224-4
274 Author index vol. 135 (1997)
Kelly, J.M., see Riches, F.M. 135, 83 Pfitzner, J., see Bischoff, H. 135, 119
Kerry, N.L., M. Abbey, Red wine and fractionated phenolic com- Pfohl, M., R.P. Naoumova, C. Neuwirth, A. Sussekov, J.
pounds prepared from red wine inhibit low density lipoprotein Smykowski, N.B. Rendell, G.W. Taylor, F.J. Seif, G.R. Thomp-
oxidation in vitro 135, 93 son, Upregulation of cholesterol synthesis after acute reduction of
Kobori, S., see Anami, Y. 135, 225 low density lipoprotein by apheresis in normocholesterolaemic
Kobori, S., see Yano, T. 135, 57 subjects: evidence for a threshold effect 135,257
Kondo, K., see Takeshita, S. 135, 187 Phivthongg-aNm, L., see Brandes, R.P. 135, 49
Pilcher, G.J., see Raal, F.J. 135, 249
Lagarde, J.-P., see Abdel-Wareth, L.O. 135, 181 Pimstone, S.N., see Abdel-Wareth, L.O. 135, 181
Laskarzewski, P., see Raal, F.J. 135, 249 Porter, M.C., see Bischoff, H. 135, 119
La Via, M., see Lopes-Virella, M.F. 135, 161 Powell, J.T., see Walton, LJ. 135,65
Lebherz, C., see Brandes, R.P. 135, 49 Pritchard, H., see Abdel-Wareth, L.O. 135, 181
Lee, F.-Y., see Yen, H.-C. 135, 29 Pugach, I.M., see Andreeva, E.R. 135,19
Lehmann, E.D., R.G. Gosling, In vivo determinants of arterial
biophysical properties: methodological considerations 135, 263 Qi, X.L., see Dart, A.M. 135, 269
Llorente-Cortés, V., see Martinez-Gonzalez, J. 135, 213
Lopes-Virella, M.F., N. Binzafar, S. Rackley, Akira Takei, M. La Raal, F.J.,G.J. Pilcher, D.R. Illingworth, A.S. Pappu, E.A. Stein, P.
Via, G. Virella, The uptake of LDL-IC by human macrophages:
Laskarzewski, Y.B. Mitchel, M.R. Melino, Expanded-dose simvas-
predominant involvement of the FcyRI receptor 135, 161 tatin is effective in homozygous familial hypercholestero-
laemia 135, 249
Mandet, C., see Péterszegi, G. 135, 103
Rackley, S., see Lopes-Virella, M.F. 135, 161
Martinez-Gonzalez, J., M. Vinials, F. Vidal, V. Llorente-Cortés, L.
Rafique, S., see Graham, A. 135, 193
Badimon, Mevalonate deprivation impairs IGF-I/insulin signaling
Raisonnier, A., see Abdel-Wareth, LO. 135, 181
in human vascular smooth muscle cells 135, 213
Rehnovist, N., see Held, C. 135, 109
Matsuda, H., see Anami, Y. 135, 225
Rendell, N.B., see Pfohl, M. 135, 257
Matsuda, H., see Yano,T. 135, 57
Riches, F.M., G.F. Watts, R.P. Naoumova, J.M. Kelly, K.D. Croft,
Matsuda, I., see Ohta, T. 135, 205
G.R. Thompson, Direct association between the hepatic secretion
Matsumura, T., see Anami, Y. 135, 225
of very-low-density lipoprotein apolipoprotein B-100 and plasma
Matsumura, T., see Yano, T. 135, 57
mevalonic acid and lathosterol concentrations in man 135, 83
Maung, K.K., see Ohta, T. 135, 205
Robert, L., see Péterszegi, G. 135, 103
Mc Eneny, J., see Mc Manus, J. 135, 73
Mc Manus, J., J. Mc Eneny, W. Thompson, I.S. Young, The effect of
Sakai, M., see Anami, Y. 135, 225
hormone replacement therapy on the oxidation of low density
Sakai, M.,see Yano, T. 135, 57
lipoprotein in postmenopausal women 135, 73
Saku, K., see Ohta, T. 135, 205
Melino, M.R., see Raal, F.J. 135, 249
Sato, T., see Takeshita,S. 135, 187
Mitchel, Y.B., see Raal, F.J. 135, 249
Schmidt, D., see Bischoff, H. 135, 119
Migge, A., see Brandes, R.P. 135, 49
Seif, F.J., see Pfohl,M. 135, 257
Shichiri, M., see Anami, Y. 135, 225
Nagata, N., see Ohta, T. 135, 205
Shichiri, M., see Yano, T. 135,57
Naito, M., H. Nomura, T. Esaki, A. Iguchi, Characteristics of
Shimada, K., see Irokawa, M. 135,9
macrophage-derived foam cells isolated from atherosclerotic lesions
Shinoda, Y., see Irokawa, M. 135, 9
of rabbits 135, 241
Shionoiri, F., see Harada, K. 135, 235
Naoumova, R.P., see Pfohl, M. 135, 257
Smart, F.W., see Tao, Z. 135, 171
Naoumova, R.P., see Riches, F.M. 135, 83
Smykowski, J., see Pfohl, M. 135, 257
Neuwirth, C., see Pfohl, M. 135, 257
Stein, E.A., see Raal, FJ. 135, 249
Nishikawa, T., see Anami, Y. 135, 225
Suematsu, M., see Irokawa, M. 135, 9
Nishinaga, M., see Irokawa, M. 135, 9
Sun, L., see Harada, K. 135, 235
Nishiyama, Y., see Takeshita,S. 135, 187
Sussekov, A., see Pfohl,M. 135, 257
Nomura, H., see Naito, M. 135, 241
Ochiai, M., see Takeshita, S. 135, 187 Takata, K., see Ohta, T. 135, 205
Ohashi, K., see Harada, K. 135, 235 Takemura, T., see Anami, Y. 135, 225
Ohta, T., K. Saku, K. Takata, N. Nagata, K.K. Maung, I. Matsuda, Takeshita, S., T. Isshiki, M. Ochiai, T. Ishikawa, Y. Nishiyama, T.
Fusano, H. Toyoizumi, K. Kondo, Y. Ono, T. Sato, Systemic
Fractional esterification rate of cholesterol in high density lipo-
protein (HDL) can predict the particle size of low density lipo- inflammatory responses in acute coronary syndrome: increased
protein and HDL in patients with coronary heart disease 135, 205 activity observed in polymorphonuclear leukocytes but not T
Ono, Y., see Takeshita, S. 135, 187 lymphocytes 135, 187
Orekhov, A.N., see Andreeva, E.R. 135, 19 Talmud, P.J., see Fisher, R.M. 135, 145
Osuga, J.-i., see Harada, K. 135, 235 Tao, Z, F.W. Smart, J.E. Figueroa, D.L. Glancy, P. Vijayagopal,
Owen, J.S., see Graham, A. 135, 193 Elevated expression of proteoglycans in proliferating vascular
smooth muscle cells 135, 171
Pappu, A.S., see Raal, F.J. 135, 249 Taylor, G.W., see Pfohl, M. 135, 257
Parums, D.V., see Walton, L.J. 135, 65 Texier, S., see Péterszegi,G. 135, 103
Péterszegi, G., C. Mandet, S. Texier, L. Robert, P. Bruneval, Thomas, G., see Bischoff, H. 135, 119
Lymphocytes in human atherosclerotic plaque exhibit the elastin- Thompson, G.R., see Pfohl, M. 135, 257
laminin receptor: potential role in atherogenesis 135, 103 Thompson, G.R., see Riches, F.M. 135, 83
Petzinna, D., see Bischoff, H. 135, 119 Thompson, W., see Mc Manus, J. 135, 73
Author index vol. 135 (1997)
Tijburg, L.B.M., S.A. Wiseman, G. W. Meijer, J.A. Weststrate, Weststrate, J.A., see Tijburg, L.B.M. 135, 37
Effects of green tea, black tea and dietary lipophilic antioxidants Wiseman, S.A., see Tijburg, L.B.M. 135, 37
on LDL oxidizability and atherosclerosis in hypercholesterolaemic W. Meijer, G., see Tijburg, L.B.M. 135, 37
rabbits 135, 37
Toyoizumi, H., see Takeshita, S. 135, 187 Yagyu, H., see Harada, K. 135, 235
Yahagi, N., see Harada, K. 135, 235
Vidal, F., see Martinez-Gonzalez, J. 135, 213 Yamada, N., see Harada, K. 135, 235
Vijayagopal, P., see Tao, Z. 135, 171 Yano, T., see Anami, Y. 135, 225
Viiials, M., see Martinez-Gonzalez, J. 135, 213 Yano, T., S. Kobori, M. Sakai, Y. Anami, T. Matsumura, H.
Virella, G., see Lopes-Virella, M.F. 135, 161 Matsuda, M. Kasho, M. Shichiri, B-very low density lipoprotein
induces triglyceride accumulation through receptor mediated endo-
Walton, L.J., J.T. Powell, D.V. Parums, Unrestricted usage of im- cytotic pathway in 3T3-L1 adipocytes 135, 57
munoglobulin heavy chain genes in B cells infiltrating the wall of Yazaki, Y., see Harada, K. 135, 235
atherosclerotic abdominal aortic aneurysms 135, 65 Yen, H.-C., F.-Y. Lee, L.-Y. Chau, Analysis of the T cell receptor Vf
Watts, G.F., see Riches, F.M. 135, 83 repertoire in human aortic aneurysms 135, 29
atherosclerosis
Atherosclerosis 135 (1997) 276—277
Subject index
Volume 135 (1997)
Activation 135, 103 HMG-CoA reductase inhibitor 135, 257
Acute coronary syndrome 135, 187 HMG CoA reductase inhibitors 135, 249
Aneurysm 135, 29, 65 Homozygous familial hypercholesterolaemia 135, 249
Angina pectoris 135, 109 Hormone replacement therapy 135, 73
Animal model 135, 1 Human aorta 135, 19
Anitschkow 135,1 Human lymphocytes 135, 103
Antibody 135, 161 Human mesangial cell 135, 225
Antioxidant 135, 73, 93, 193 Human £-VLDL 135, 225
Antioxidants 135, 37 3-Hydroxy-3-methylglutaryl Coenzyme A reductase inhibitors 135,
Antithrombin III 135, 9 213
Apolipoprotein B-100 135, 83 Hypercholesterolemia 135, 49, 181
Apolipoproteins 135, 109
Apoptosis 135, 235 Immune response 135, 187
Arterial distensibility 135, 263 Immunocytochemistry 135, 19
Atherogenesis 135, 171 Infection 135,1
Atherosclerosis 135, 1, 19, 37, 103, 119, 193, 205, 225, 235, 241 Inflammation 135, 65
Insulin 135, 213
Balloon denudation 135, 1 Insulin-like growth factor 135, 213
B cell clonality 135, 65
Body mass index 135, 145 Lathosterol 135, 83, 257
LDL binding 135, 171
B-Carotene 135, 37 LDL oxidation 135, 37, 73
CD68 macrophage associated antigen 135, 19 LDL receptor 135, 161
c-fos 135, 213 LDL-size 135, 205
Chinese 135, 181 Lipids 135, 73
Cholesterol 135, 1, 235, 241 Lipoprotein lipase 135, 57
Compliance 135, 263 Lipoproteins 135, 109
Coronary heart disease 135, 205 Low density lipoprotein 135, 73, 93
Low density lipoprotein-cholesterol 135, 249
Dogs 135, 119 Lymphocytes 135, 29
Lysozyme 135, 241
EDRF 135, 9
Elastase 135, 103 Macrophage 135, 161, 241
Elastin-laminin receptor 135, 103 Macrophages 135, 235
Endothelial-derived hyperpolarizing factor 135, 49 Mevalonic acid 135, 83, 257
Estrogen 135, 1
Necrosis 135, 235
Familial defective apo B-100 135, 181 Neutrophils 135, 187
Familial type III hyperlipoproteinemia 135, 225 N®&-nitro-L-arginine 135, 49
FERyp, 135, 205 Nitric oxide 135, 49
Foam cell 135, 225, 241 Non-specific esterase 135, 241
Foam cells 135, 235
Oestrogen 135, 73
Genetic variation 135, 145 Oxidation 135, 93
Oxidative stress 135, 9
Haplotype 135, 181
High-density lipoprotein subclasses 135, 193 Paraoxonase 135, 193
HMG-CoA-reductase inhibition 135, 119 Phenolic compounds 135, 93
PIT $0021-9150(97)00225-6
Subject index vol. 135 (1997)
Phospholipids 135, 193 Smooth muscle cell proliferation 135, 171
Prognosis 135, 109 Stiffness 135, 263
Proteoglycan 135, 9 Superoxide 135, 241
Proteoglycan synthesis 135, 171
Pulse wave reflections 135, 263 T cell antigen receptor 135, 29
Pulse wave velocity 135, 263 Tea 135, 37
Thrombosis 135, 9
Rabbit 135, 1, 37 Tissue selectivity 135, 119
Rabbits 135, 119 3T3-L1 cells 135, 57
Rats 135, 119 T lymphocytes 135, 187
Red wine 135, 93 Triacylglycerol 135, 145
Renal artery 135, 49 Triglyceride accumulation 135, 57
Signaling pathways 135, 213 VDJ rearrangement 135, 65
Simvastatin 135, 249, 257 Very-low-density lipoprotein 135, 83
Smooth muscle z-actin 135, 19 Very low density lipoprotein receptor 135, 57
Smooth muscle cell 135, 213 Vitamin E 135, 37